Cargando…

2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty

PURPOSE: Penile inversion vaginoplasty (PIV) is the most common gender affirming genital procedure for transfeminine patients. The purpose of this study was to investigate the impact of tranexamic acid (TXA), an antifibrinolytic, on bleeding and bleeding-related complications in vaginoplasty surgery...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunderson, Kirsten A., Edalatpour, Armin, Wirth, Peter, Rose, Katherine, Gast, Katherine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312833/
http://dx.doi.org/10.1097/01.GOX.0000770144.39567.ee
_version_ 1783729211062616064
author Gunderson, Kirsten A.
Edalatpour, Armin
Wirth, Peter
Rose, Katherine
Gast, Katherine M.
author_facet Gunderson, Kirsten A.
Edalatpour, Armin
Wirth, Peter
Rose, Katherine
Gast, Katherine M.
author_sort Gunderson, Kirsten A.
collection PubMed
description PURPOSE: Penile inversion vaginoplasty (PIV) is the most common gender affirming genital procedure for transfeminine patients. The purpose of this study was to investigate the impact of tranexamic acid (TXA), an antifibrinolytic, on bleeding and bleeding-related complications in vaginoplasty surgery. METHODS: Retrospective chart review was performed on patients undergoing PIV from February 2018 through March 2020 by the senior author (K.G.) at the University of Wisconsin Hospital and Clinics. Patients who received TXA received a combination of topical and intravenous TXA. Data collected includes patient demographics (age, body mass index, race, comorbidities, and tobacco and illicit drug use), intraoperative data (duration of surgery, estimated blood loss, fluid administration, TXA use and dose, and complications), and postoperative data (drain output, complications within 30 days, and revision surgery). Subgroup analysis on the effect of TXA was performed using independent sample t-test. RESULTS: Seventy-four patients were included in this study with 56 patients receiving TXA and 18 patients who had surgery prior to initiation of TXA protocol. There were no thromboembolic events observed in the TXA or the non-TXA group. Ninety percent of all complications were Clavien-Dindo Grade 1 and did not require intervention. There was a significantly lower EBL in the TXA group compared to the no TXA cohort (299.1 ± 64.3 vs. 347.2 ± 84.8, p=0.013). Patients who received TXA had significantly fewer wound related complications than those who did not receive TXA (21.4% vs. 66.7%, p<0.0001). Similarly, there were fewer neo-vagina skin graft failures in the TXA group, though this did not reach significance (0.0% vs. 11.1%, p=0.057). There was no significant difference in drain output between the two groups. CONCLUSION: No thromboembolic events were observed with intravenous and topical tranexamic acid use in transfeminine patients undergoing penile inversion vaginoplasty surgery. TXA was also associated with lower intraoperative blood loss as well as fewer wound healing complications. Further research is needed to further study its use in gender affirmation surgery.
format Online
Article
Text
id pubmed-8312833
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-83128332021-07-27 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty Gunderson, Kirsten A. Edalatpour, Armin Wirth, Peter Rose, Katherine Gast, Katherine M. Plast Reconstr Surg Glob Open PSRC 2021 Abstract Supplement PURPOSE: Penile inversion vaginoplasty (PIV) is the most common gender affirming genital procedure for transfeminine patients. The purpose of this study was to investigate the impact of tranexamic acid (TXA), an antifibrinolytic, on bleeding and bleeding-related complications in vaginoplasty surgery. METHODS: Retrospective chart review was performed on patients undergoing PIV from February 2018 through March 2020 by the senior author (K.G.) at the University of Wisconsin Hospital and Clinics. Patients who received TXA received a combination of topical and intravenous TXA. Data collected includes patient demographics (age, body mass index, race, comorbidities, and tobacco and illicit drug use), intraoperative data (duration of surgery, estimated blood loss, fluid administration, TXA use and dose, and complications), and postoperative data (drain output, complications within 30 days, and revision surgery). Subgroup analysis on the effect of TXA was performed using independent sample t-test. RESULTS: Seventy-four patients were included in this study with 56 patients receiving TXA and 18 patients who had surgery prior to initiation of TXA protocol. There were no thromboembolic events observed in the TXA or the non-TXA group. Ninety percent of all complications were Clavien-Dindo Grade 1 and did not require intervention. There was a significantly lower EBL in the TXA group compared to the no TXA cohort (299.1 ± 64.3 vs. 347.2 ± 84.8, p=0.013). Patients who received TXA had significantly fewer wound related complications than those who did not receive TXA (21.4% vs. 66.7%, p<0.0001). Similarly, there were fewer neo-vagina skin graft failures in the TXA group, though this did not reach significance (0.0% vs. 11.1%, p=0.057). There was no significant difference in drain output between the two groups. CONCLUSION: No thromboembolic events were observed with intravenous and topical tranexamic acid use in transfeminine patients undergoing penile inversion vaginoplasty surgery. TXA was also associated with lower intraoperative blood loss as well as fewer wound healing complications. Further research is needed to further study its use in gender affirmation surgery. Lippincott Williams & Wilkins 2021-07-26 /pmc/articles/PMC8312833/ http://dx.doi.org/10.1097/01.GOX.0000770144.39567.ee Text en Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle PSRC 2021 Abstract Supplement
Gunderson, Kirsten A.
Edalatpour, Armin
Wirth, Peter
Rose, Katherine
Gast, Katherine M.
2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_full 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_fullStr 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_full_unstemmed 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_short 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_sort 2: tranexamic acid is associated with decreased intraoperative blood loss and wound healing complication rate in penile inversion vaginoplasty
topic PSRC 2021 Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312833/
http://dx.doi.org/10.1097/01.GOX.0000770144.39567.ee
work_keys_str_mv AT gundersonkirstena 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty
AT edalatpourarmin 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty
AT wirthpeter 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty
AT rosekatherine 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty
AT gastkatherinem 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty